Welcome
The Tanz Centre for Research in Neurodegenerative Diseases at the University of Toronto is a world leader in scientific research on Alzheimer’s and other dementias, ALS, and Parkinson’s.
Our highly productive researchers and trainees are advancing knowledge of these debilitating brain disorders, from genetics and molecular mechanisms of disease through to translational research driving for better treatments and strategies for prevention.
Mar 13, 2025
Researchers at the University of Toronto have developed a skin-based test that can detect signature features of progressive supranuclear palsy, pointing toward the potential for a minimally invasive diagnostic test.
Feb 6, 2025
Neuropeutics Inc, a start-up company launched by University of Toronto researchers to tackle neurodegenerative diseases, has partnered with medical research charity LifeArc to develop a new drug for amyotrophic lateral sclerosis (ALS) and other neurodegenerative conditions.
Dec 9, 2024
A new study from University Health Network and the University of Toronto has found that caregiver characteristics can have a significant effect on the most frequently used measure of severity in Alzheimer’s disease.
With Your Support
With our new leadership and your investment, we will stimulate new research pathways towards understanding neurodegenerative diseases.
